137 related articles for article (PubMed ID: 18231794)
21. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Imaizumi T
Mol Med; 2007; 13(3-4):185-9. PubMed ID: 17592553
[TBL] [Abstract][Full Text] [Related]
22. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
23. Calcitriol treatment increases serum levels of the soluble receptor of advanced glycation end products in hemodialysis patients with secondary hyperparathyroidism.
Sung JY; Chung W; Kim AJ; Kim HS; Ro H; Chang JH; Lee HH; Jung JY
Tohoku J Exp Med; 2013 May; 230(1):59-66. PubMed ID: 23748365
[TBL] [Abstract][Full Text] [Related]
24. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
Lee SJ; Oh HJ; Choi BY; Jang YJ; Lee JY; Park JK; Song YW
J Immunol Res; 2016; 2016():5781070. PubMed ID: 28074193
[TBL] [Abstract][Full Text] [Related]
25. Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.
García-Carrasco M; Pizcueta P; Cervera R; Ramos-Casals M; Sisó A; de La Red G; Ingelmo M; Font J; Engel P
Ann Rheum Dis; 2000 Apr; 59(4):297-9. PubMed ID: 10733478
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of circulating soluble RAGE in patients with severe sepsis.
Matsumoto H; Matsumoto N; Ogura H; Shimazaki J; Yamakawa K; Yamamoto K; Shimazu T
J Trauma Acute Care Surg; 2015 Jun; 78(6):1086-93; discussion 1093-4. PubMed ID: 26002402
[TBL] [Abstract][Full Text] [Related]
27. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.
Krejsek J; Slezák R; Kopecky O; Derner V; Andrys C
Clin Rheumatol; 1997 Mar; 16(2):149-53. PubMed ID: 9093796
[TBL] [Abstract][Full Text] [Related]
28. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
30. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
[TBL] [Abstract][Full Text] [Related]
31. Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?
Lorenzi R; Grossin N; Lambert M; Daroux M; Adjoutah Z; Flahaut C; Jacolot P; Tessier FJ; Lefranc D; Desremaux P; Dubucquoi S; Boulanger E
Ann Clin Biochem; 2014 Mar; 51(Pt 2):248-57. PubMed ID: 23982266
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
[TBL] [Abstract][Full Text] [Related]
33. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia.
Kwon JH; Kim YH; Kwon JY; Park YW
J Perinat Med; 2011 Sep; 39(5):507-13. PubMed ID: 21767223
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to CD4 in primary Sjögren's syndrome.
Henriksson G; Manthorpe R; Bredberg A
Rheumatology (Oxford); 2000 Feb; 39(2):142-7. PubMed ID: 10725063
[TBL] [Abstract][Full Text] [Related]
37. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis for modified Schall's classification by stimulation test with dynamic scintigraphy in Sjögren's syndrome.
Zhu GW; Gao Z; Feng HB; Qiu JJ
Int J Rheum Dis; 2020 Mar; 23(3):381-391. PubMed ID: 31863640
[TBL] [Abstract][Full Text] [Related]
39. Primary and secondary Sjögren's syndrome in children--a comparative study.
Stiller M; Golder W; Döring E; Biedermann T
Clin Oral Investig; 2000 Sep; 4(3):176-82. PubMed ID: 11000325
[TBL] [Abstract][Full Text] [Related]
40. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
